Publications by authors named "Chengbin Hu"

Claim this Profile
E
EGFR and CYP signaling disruption underlies 6PPD-quinone hepatotoxicity: Insights from a network and machine learning approach.
Wenjie Zhang, Banghua Wu, Chengbin Hu, Weifeng Rong, Yongshun Huang, Shijie Hu

Toxicology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal integrative cell-free DNA analysis in gestational diabetes mellitus.
Zhuangyuan Tang, Shuo Wang, Xi Li, Chengbin Hu, Qiangrong Zhai, Huikun Liu, Minjuan Huang, Huanhuan Zhu, Gongshu Liu

Cell Rep Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-learning neural network as a prediction model in non-invasive prenatal testing to detect fetal SNVs.
Yiming Qi, Chengbin Hu, Jiexia Yang, Ya Gao, Aihua Yin

J Transl Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction for: CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma.
Dan Zi, Qing Li, Cheng-Xiong Xu, Zhi-Wei Zhou, Guan-Bin Song, Cheng-Bin Hu, Shu-Feng Zhou

Aging (Albany NY)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction for: CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma.
Dan Zi, Qing Li, Cheng-Xiong Xu, Zhi-Wei Zhou, Guan-Bin Song, Cheng-Bin Hu, Shu-Feng Zhou

Aging (Albany NY)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma.
Dan Zi, Qing Li, Cheng-Xiong Xu, Zhi-Wei Zhou, Guan-Bin Song, Cheng-Bin Hu, Shu-Feng Zhou

Aging (Albany NY)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity.
Yi Zhang, Zhi-Wei Zhou, Hua Jin, Chengbin Hu, Zhi-Xu He, Shu-Feng Zhou

Drug Des Devel Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancer.
Chunxia Cao, Ruli Gao, Min Zhang, Antonio L Amelio, Mohammad Fallahi, Chengbin Hu

J Natl Cancer Inst· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief report: Blockade of Notch signaling in muscle stem cells causes muscular dystrophic phenotype and impaired muscle regeneration.
Shuibin Lin, Huangxuan Shen, Baofeng Jin, Yumei Gu, Zirong Chen, Chunxia Cao, Chengbin Hu

Stem Cells· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic and functional analyses reveal the role of chromatin reader SFMBT1 in regulating epigenetic silencing and the myogenic gene program.
Shuibin Lin, Huangxuan Shen, Jian-Liang Li, Shaojun Tang, Yumei Gu, Chengbin Hu

J Biol Chem· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methyltransferase inhibitor CDA-II inhibits myogenic differentiation.
Zirong Chen, Guorong Jin, Shuibin Lin, Xiumei Lin, Yumei Gu, Yujuan Zhu, Chengbin Hu, Huangxuan Shen

Biochem Biophys Res Commun· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis